Back to Authors

Wu, Jianmin

https://orcid.org/0000-0002-8876-128X

Mayo Clinic

Mayo Clinic

Citations 2

Neuropilin-2 Promotes Extravasation and Metastasis by Interacting with Endothelial α5 Integrin
Cao, Ying , Hoeppner, Luke H. , Bach, Steven , Guangqi, E, Wang, Enfeng , Wu, Jianmin , Cowley, Mark J. , Chang, David K. , Waddell, Nicola , Grimmond, Sean M. , Biankin, Andrew V. , Daly, Roger J. , Zhang, Xiao Hui , E, Guangqi, Guo, Yan , Mukhopadhyay, Debabrata , Waddell, Nicola , Chang, David , Grimmond, Sean M , Biankin, Andrew V

Cancer Research | May 21, 2013 | Volume: 73 | Issue: 14 | Pages: 4579-4590

10.1158/0008-5472.can-13-0529 Get It

Abstract Metastasis, the leading cause of cancer death, requires tumor cell intravasation, migration through the bloodstream, arrest within capillaries, and extravasation to invade distant tissues. Few mechanistic details have been reported thus far regarding the extravasation process or re-entry of circulating tumor cells at metastatic sites. Here, we show that neuropilin-2 (NRP-2), a multifunctional nonkinase receptor for semaphorins, vascular endothelial growth factor (VEGF), and other growth factors, expressed on cancer cells interacts with α5 integrin on endothelial cells to mediate vascular extravasation and metastasis in zebrafish and murine xenograft models of clear cell renal cell carcinoma (RCC) and pancreatic adenocarcinoma. In tissue from patients with RCC, NRP-2 expression is positively correlated with tumor grade and is highest in metastatic tumors. In a prospectively acquired cohort of patients with pancreatic cancer, high NRP-2 expression cosegregated with poor prognosis. Through biochemical approaches as well as Atomic Force Microscopy (AFM), we describe a unique mechanism through which NRP-2 expressed on cancer cells interacts with α5 integrin on endothelial cells to mediate vascular adhesion and extravasation. Taken together, our studies reveal a clinically significant role of NRP-2 in cancer cell extravasation and promotion of metastasis. Cancer Res; 73(14); 4579–90. ©2013 AACR.
Microcephalin Regulates BRCA2 and Rad51-Associated DNA Double-Strand Break Repair
Wu, Xianglin, Mondal, Gourish, Yang, Lin , Rowley, Matthew, Wang, Xianshu , Wu, Jianmin , Pankratz, V. Shane , Couch, Fergus J.

Cancer Research | July 1, 2009 | Volume: 69 | Issue: 13 | Pages: 5531-5536

10.1158/0008-5472.can-08-4834 Get It

Abstract Microcephalin (MCPH1) is a BRCA1 COOH terminal (BRCT) domain containing protein involved in the cellular response to DNA damage that has been implicated in autosomal recessive primary microcephaly. MCPH1 is recruited to sites of DNA double-strand breaks by phosphorylated histone H2AX (γH2AX), but the mechanism by which MCPH1 contributes to the repair process remains to be determined. Here, we show that MCPH1 binds to BRCA2 and regulates the localization of BRCA2 and Rad51 at sites of DNA damage. The interaction occurs through the NH2 terminus of BRCA2 and the COOH terminal BRCT domains of MCPH1. Disruption of the interaction between MCPH1 and BRCA2 has no effect on the ability of BRCA2 to form a complex with Rad51 but is associated with substantially reduced levels of both BRCA2 and Rad51 at sites of DNA double-strand breaks. Uncoupling of MCPH1 from BRCA2 also interferes with Rad51-dependent and BRCA2-dependent homologous recombination repair activity. These results suggest that the role of MCPH1 in the DNA damage response is in part associated with the ability to localize BRCA2 to sites of DNA double-stand breaks. [Cancer Res 2009;69(13):5531–6]